Basic Information
RNALocate ID: | RLID:11004120 |
RNA Symbol: | hsa-miR-708-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-708-5p |
RNA ID: | miRBase:MIMAT0004926 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002694 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002695 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11004121 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000717 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001599 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-708-5p | Oral squamous cell carcinoma | MNDR-E-MI-68056 |
MNDR | hsa-miR-708-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-68057 |
MNDR | hsa-miR-708-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-68058 |
MNDR | hsa-miR-708-5p | Ovarian clear cell carcinoma | MNDR-E-MI-68059 |
MNDR | hsa-miR-708-5p | Lymphoma | MNDR-E-MI-68060 |
MNDR | hsa-miR-708-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68061 |
MNDR | hsa-miR-708-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68062 |
MNDR | hsa-miR-708-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68063 |
MNDR | hsa-miR-708-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68064 |
MNDR | hsa-miR-708-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68065 |
MNDR | hsa-miR-708-5p | Breast cancer luminal | MNDR-E-MI-68066 |
MNDR | hsa-miR-708-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68067 |
MNDR | hsa-miR-708-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-68068 |
MNDR | hsa-miR-708-5p | Small intestine cancer | MNDR-E-MI-68069 |
MNDR | hsa-miR-708-5p | Prostate cancer | MNDR-E-MI-68070 |
MNDR | hsa-miR-708-5p | Chronic lymphocytic leukemia | MNDR-E-MI-68071 |
MNDR | hsa-miR-708-5p | Gastric cancer | MNDR-E-MI-68072 |
MNDR | hsa-miR-708-5p | Alzheimer disease | MNDR-E-MI-68073 |
MNDR | hsa-miR-708-5p | Urinary bladder cancer | MNDR-E-MI-68074 |
MNDR | hsa-miR-708-5p | Esophageal carcinoma | MNDR-E-MI-68075 |
MNDR | hsa-miR-708-5p | Dysautonomia familial | MNDR-E-MI-68076 |
MNDR | hsa-miR-708-5p | Graves disease | MNDR-E-MI-68077 |
MNDR | hsa-miR-708-5p | Leukemia | MNDR-E-MI-68078 |
MNDR | hsa-miR-708-5p | Huntington disease | MNDR-E-MI-68079 |
MNDR | hsa-miR-708-5p | Lung cancer | MNDR-E-MI-68080 |
MNDR | hsa-miR-708-5p | Parkinson disease | MNDR-E-MI-68081 |
MNDR | hsa-miR-708-5p | Primary pulmonary hypertension | MNDR-E-MI-68082 |
MNDR | hsa-miR-708-5p | Basal-like breast cancer | MNDR-E-MI-68083 |
MNDR | hsa-miR-708-5p | Cancer | MNDR-E-MI-68084 |
MNDR | hsa-miR-708-5p | Thyroid cancer | MNDR-E-MI-68085 |
MNDR | hsa-miR-708-5p | Pancreatic cancer | MNDR-E-MI-68086 |
MNDR | hsa-miR-708-5p | Rectum adenocarcinoma | MNDR-E-MI-68087 |
MNDR | hsa-miR-708-5p | Nephroblastoma | MNDR-E-MI-68088 |
MNDR | hsa-miR-708-5p | Colon cancer | MNDR-E-MI-68089 |
MNDR | hsa-miR-708-5p | Colon adenocarcinoma | MNDR-E-MI-68090 |
MNDR | hsa-miR-708-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-68091 |
MNDR | hsa-miR-708-5p | Prostate adenocarcinoma | MNDR-E-MI-68092 |
MNDR | hsa-miR-708-5p | Laryngeal neoplasms | MNDR-E-MI-68093 |
MNDR | hsa-miR-708-5p | Endometriosis | MNDR-E-MI-68094 |
MNDR | hsa-miR-708-5p | Carcinoma ductal breast | MNDR-E-MI-68095 |
MNDR | hsa-miR-708-5p | Glioblastoma | MNDR-E-MI-68096 |
MNDR | hsa-miR-708-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-68097 |
MNDR | hsa-miR-708-5p | Ewing sarcoma | MNDR-E-MI-68098 |
MNDR | hsa-miR-708-5p | Gastric adenocarcinoma | MNDR-E-MI-68099 |
MNDR | hsa-miR-708-5p | Lung squamous cell carcinoma | MNDR-E-MI-68100 |
MNDR | hsa-miR-708-5p | Carcinoma lung non-small-cell | MNDR-E-MI-68101 |
MNDR | hsa-miR-708-5p | Lung adenocarcinoma | MNDR-E-MI-68102 |
MNDR | hsa-miR-708-5p | Thyroid carcinoma | MNDR-E-MI-68103 |
MNDR | hsa-miR-708-5p | Ovarian carcinoma | MNDR-E-MI-68104 |
MNDR | hsa-miR-708-5p | Bladder urothelial carcinoma | MNDR-E-MI-68105 |
MNDR | hsa-miR-708-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68106 |
MNDR | hsa-miR-708-5p | Carcinoma renal cell | MNDR-E-MI-68107 |
MNDR | hsa-miR-708-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-68108 |
MNDR | hsa-miR-708-5p | Renal clear cell carcinoma | MNDR-E-MI-68109 |
MNDR | hsa-miR-708-5p | Biliary tract cancer | MNDR-E-MI-68110 |
MNDR | hsa-miR-708-5p | Cholangiocarcinoma | MNDR-E-MI-68111 |
MNDR | hsa-miR-708-5p | Esophageal cancer | MNDR-E-MI-68112 |
MNDR | hsa-miR-708-5p | Synovial sarcoma | MNDR-E-MI-68113 |
MNDR | hsa-miR-708-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-68114 |
MNDR | hsa-miR-708-5p | Breast invasive carcinoma | MNDR-E-MI-68115 |
MNDR | hsa-miR-708-5p | Hepatocellular carcinoma | MNDR-E-MI-68116 |
MNDR | hsa-miR-708-5p | Hodgkin lymphoma | MNDR-E-MI-68117 |
MNDR | hsa-miR-708-5p | Colorectal cancer | MNDR-E-MI-68118 |
MNDR | hsa-miR-708-5p | Nasopharynx carcinoma | MNDR-E-MI-68119 |
MNDR | hsa-miR-708-5p | Multiple myeloma | MNDR-E-MI-68120 |
MNDR | hsa-miR-708-5p | Nasopharyngeal cancer | MNDR-E-MI-68121 |
MNDR | hsa-miR-708-5p | Prostatic neoplasms | MNDR-E-MI-68122 |
MNDR | hsa-miR-708-5p | Aids dementia complex | MNDR-E-MI-68123 |
MNDR | hsa-miR-708-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-68124 |
MNDR | hsa-miR-708-5p | Breast cancer her3+ negative | MNDR-E-MI-68125 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AKT1 | Homo sapiens | RR00067020 |
TOP